APLS
Apellis Pharmaceuticals Inc.
$23.49
+$0.48(+2.09%)
65
Overall
40
Value
90
Tech
--
Quality
Market Cap
$3.01B
Volume
1.55M
52W Range
$16.10 - $35.72
Target Price
$37.25
EPS Estimates Overview
| Current Quarter | $0.73 | Next Quarter | $-0.36 |
| Current Year | $-0.64 | Next Year | $-0.93 |
| QoQ Growth | -149.3% | YoY Growth | -45.3% |
| 3Y EPS CAGR | +43.4% | Target Price | $37.25 |
| Consensus | Buy | Upside | +58.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $23.49 | +2.1% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW